JCU CORPORATIONJJ

JCU CORPORATION

3,405JPYD
+5+0.15%
At close at 06:25 GMT
JPY
No trades
See on Supercharts

4975 fundamentals

Key facts

Market capitalization‪86.82 B‬JPY
Founded1957
CEOMasashi Kimura
Websitejcu-i.com
About

JCU Corp. engages in the manufacture and sale chemicals, machines, and auxiliary equipment for surface treatment. It operates through the following segments: Chemicals Business, Machines Business, and Other Businesses. The Chemicals Business segment handles the development, manufacture, and sale of surface treatment chemicals. The Machines Business segment offers surface treatment equipment and printed circuit board cleaning equipment using plasma technology. It also constructs and sells solar power generation equipment. The Other Businesses segment deals with growing and marketing grapes and seedlings for wine making. The company was founded in December 1957 and is headquartered in Tokyo, Japan.

Ownership
‪‪25.05 M‬‬
Free Float shares
‪‪17.51 M‬‬ (69.91%)
Closely held shares
‪‪7.54 M‬‬ (30.09%)
Free Float shares
‪‪17.51 M‬‬ (69.91%)
Closely held shares
‪‪7.54 M‬‬ (30.09%)
Capital structure
Market cap
‪‪86.82 B‬‬
Debt
‪‪494.88 M‬‬
Cash & equivalents
‪‪27.67 B‬‬
Enterprise value
‪‪59.65 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪86.82 B‬‬
Price to earning ratio (P/E)
12.03x
Price to sales ratio (P/S)
3.07x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
12.03x
Price to sales ratio (P/S)
3.07x
Valuation ratios
‪0.00‬
‪1.10‬
‪2.20‬
‪3.30‬
‪4.40‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪6.00‬
‪12.00‬
‪18.00‬
‪24.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪20%‬
‪22%‬
‪24%‬
‪26%‬
‪28%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Pharmaceutical
Equipment
Other
By country
Period: 2023
China
Japan
Taiwan
Other Asia
South Korea
Other

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Actual
Estimate
Earnings
Next:May 7, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪21.00‬
‪42.00‬
‪63.00‬
‪84.00‬
Actual

Dividends

Dividend yield, history and sustainability

Dividend summary
25.03%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
2.09%
Next payment
37.00
Next ex-date
Mar 28, 2025
Dividend history
‪1.0%‬
‪1.3%‬
‪1.6%‬
‪1.9%‬
‪2.2%‬
2019
2020
2021
2022
2023
‪0.00‬
‪20.00‬
‪40.00‬
‪60.00‬
‪80.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪8.00 B‬‬
‪‪16.00 B‬‬
‪‪24.00 B‬‬
‪‪32.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪11.00 B‬‬
‪‪22.00 B‬‬
‪‪33.00 B‬‬
‪‪44.00 B‬‬
Assets
Liabilities